CBD Guides

CBD for dog seizures UK: what the trials and the law say

By the Honest CBD Co team · 31st August 2026

Peer-reviewed trials show CBD can reduce seizure days for some dogs when used alongside conventional antiepileptic drugs, but it isn’t a cure and UK regulation restricts how these products can be sold and administered to pets. No CBD product is authorised for veterinary use in the UK, so the safest first move is always a conversation with your vet, a seizure diary, and a commitment to lab-tested, low-THC products only if your vet supports the plan.

TL;DR:

CBD may reduce seizure days in some dogs when used as an add-on treatment, but effects vary and don’t eliminate seizures entirely.

Most research involves small sample sizes and short follow-up periods, so long-term safety and efficacy remain uncertain.

UK regulations prohibit selling or administering unprescribed CBD products to pets, requiring vet involvement and lab-tested, low-THC products.

Monitoring liver enzymes and drug interactions is essential, as CBD can cause mild side effects and alter anticonvulsant blood levels.

Use low-THC, clearly labelled products from an established maker your vet is comfortable with, and let the vet set and monitor the dose.

What the research shows on CBD for dog seizures UK trials
UK legal and regulatory status for CBD in pets
Side effects, monitoring, and drug interactions to watch
Choosing a UK-compliant CBD product: formulation and red flags
Dosing ranges from trials and a safe titration approach
Talking to your vet: what to bring and what to ask
Honest CBD Co’s testing standards and where this article’s limits sit
A balanced closing view on CBD for canine epilepsy
Where to start if your vet approves a CBD trial
Sources

What the research shows on CBD for dog seizures UK trials

The strongest evidence comes from a double-blinded, placebo-controlled crossover trial by Rozental et al., which tested CBD as an add-on treatment in 51 dogs with drug-resistant idiopathic epilepsy. The study found a measurable decrease in total seizures and seizure days compared with placebo, at doses that pushed towards 9 mg/kg per day. It’s one of the better-designed studies in this space precisely because it used a crossover design, meaning each dog acted as its own control, which helps cancel out the natural variability in how epilepsy behaves month to month.

A separate trial published in Frontiers in Veterinary Science used a CBD/CBDA-rich hemp extract rather than CBD alone, and reported a statistically significant drop in mean seizures and seizure days against placebo. An earlier Frontiers trial using a lower dose, around 2 mg/kg every 12 hours, found a similar pattern of benefit with a smaller side-effect burden. That detail matters: two studies using different formulations and different doses both found benefit, which suggests the effect isn’t a fluke of one particular product, but the doses and blends were not identical, so you can’t simply assume any CBD product will replicate these results.

Statistic: In owner-reported data summarised by NDSR, one crossover study found a meaningful reduction in seizure frequency in the treatment group. That’s meaningful for a dog having frequent clusters, but it also means two-thirds of the seizure burden typically remained.

None of these trials found CBD eliminated seizures outright. What they consistently found was a reduction in frequency for a subset of dogs, alongside a need to monitor liver enzymes throughout treatment. The AKC Canine Health Foundation summarises the current picture plainly: CBD may help reduce seizure frequency in some dogs with idiopathic epilepsy, but it should be viewed as adjunctive therapy, not a replacement for established antiepileptic drugs (AEDs), and larger controlled trials are still needed.

A few limitations run through nearly all of this research:

Cohorts are small, often fewer than 60 dogs, which limits how confidently results generalise to the wider dog population.
Follow-up periods are short, typically 12 weeks or less, so long-term efficacy and safety remain largely unstudied.
Products vary between trials, some using CBD isolate, others a CBD/CBDA blend, making direct comparison difficult.
Blinding and crossover design help control bias, but placebo response in epilepsy trials, in dogs and humans, tends to be high.

The practical takeaway for UK owners: current evidence supports CBD as a genuine, modest adjunct for a proportion of dogs with drug-resistant epilepsy, used on top of conventional AEDs rather than instead of them. It is not, on the evidence available, a monotherapy you’d choose over established veterinary treatment.

UK legal and regulatory status for CBD in pets

There is no authorised CBD product for animals anywhere in the UK. The Veterinary Medicines Directorate has stated this clearly, and it has real consequences for how CBD reaches a dog with seizures. Supplying or administering an unauthorised CBD product to an animal without a veterinary prescription is technically an offence under Regulation 8 of the Veterinary Medicines Regulations. That regulation exists to stop unproven, unregulated substances being sold as medicines, and CBD for pets currently sits in that unlicensed space.

This doesn’t mean CBD is banned outright for pets, but it does mean the legal route runs through your vet, not the pet aisle. When conventional treatments aren’t controlling a dog’s seizures well enough, vets can sometimes use what’s known as the prescribing cascade, a legal framework that allows a vet to prescribe a human-licensed medicine when no authorised veterinary equivalent exists. In epilepsy specifically, this occasionally means prescribing Epidyolex, a human CBD medicine licensed for certain rare epilepsy syndromes in people. Access through this route is rare, cost can be a genuine barrier, and it sits entirely at your vet’s clinical discretion.

For everyday practical purposes, here’s what UK ownership looks like right now:

Ask your vet directly whether a prescription route, including the cascade, is appropriate for your dog’s specific epilepsy diagnosis.
Keep a written record of any conversation and any product discussed, including batch numbers and certificates of analysis (COAs).
Treat unlabelled “pet CBD” products from anonymous sellers as a legal and safety grey area, not a shortcut around veterinary involvement.
Understand that a shop selling general wellness CBD oil for humans is not the same as a licensed veterinary product, even if the label mentions pets.

Our article on CBD for dogs UK safety and legality goes into more depth on how this framework plays out for everyday pet owners, and it’s worth reading alongside a conversation with your vet rather than instead of one. The regulatory picture may shift over time as more UK trials emerge, but for now, the prescribing cascade and vet oversight are the legitimate route, not general retail purchase.

Side effects, monitoring, and drug interactions to watch

CBD isn’t risk-free, and the trial data is fairly consistent about what to watch for. The most commonly reported adverse effects across studies are mild ataxia (wobbliness or uncoordinated movement), somnolence (sedation or excessive sleepiness), and gastrointestinal upset such as loose stools or reduced appetite. These tend to appear early in treatment and often settle as the dog adjusts, though not always.

The more clinically significant finding, reported in both the Rozental et al. trial and the Frontiers CBD/CBDA study, is a transient rise in liver enzymes, particularly alkaline phosphatase (ALP). This is why routine bloodwork isn’t optional if your dog starts CBD alongside prescribed medication. It’s a monitoring requirement, not a nice-to-have.

Interactions matter here too. CBD is metabolised through the liver, using some of the same enzyme pathways as common canine antiepileptic drugs, including phenobarbital, zonisamide, and potassium bromide. That shared pathway can alter how quickly those drugs are cleared from the body, which can push blood levels of the AED higher than expected even without a dose change. Cornell University’s veterinary college notes this as one reason CBD should never be introduced without veterinary awareness when a dog is already on seizure medication.

Practical monitoring points to raise with your vet before starting CBD:

Baseline liver enzyme panel (including ALP and ALT) before treatment begins, repeated at intervals your vet sets.
Serum monitoring of phenobarbital or other AED levels if your dog is on one, since CBD can shift these.
A clear plan for what counts as a reportable side effect versus something to simply note in the diary.
An agreed point at which you’d stop CBD and contact your vet urgently, rather than waiting to see if it passes.

Pro Tip: Start CBD on a day when you can observe your dog closely for several hours afterwards, ideally a weekend. Sedation and ataxia usually show up within the first two hours, and catching it early makes the conversation with your vet far more useful than a vague “he seemed a bit off yesterday”.

Stop CBD and seek urgent veterinary care if you see marked sedation that doesn’t improve, seizures that become more frequent or severe after starting treatment, or any sign consistent with toxicity such as vomiting alongside disorientation. These are not “wait and see” situations.

Choosing a UK-compliant CBD product: formulation and red flags

Not all CBD products carry the same risk profile, and the distinction matters more for dogs than it does for people. Full-spectrum products retain the plant’s other cannabinoids, including trace THC, and some research suggests these compounds work together in what’s sometimes called an entourage effect. But that same trace THC, generally harmless in the tiny amounts permitted for human products, poses a real toxicity risk for dogs, whose endocannabinoid systems are considerably more sensitive to it than ours.

For UK dogs specifically, broad-spectrum or isolate products are usually the more cautious choice, since they’re formulated to remove or exclude THC almost entirely while keeping CBD’s other properties intact. This is a genuine trade-off rather than a simple upgrade. You may lose some of the entourage effect associated with full-spectrum extracts, but you meaningfully reduce the risk of accidental THC exposure in an animal that can’t tell you something feels wrong.

Whatever formulation you land on, a handful of quality checks are non-negotiable:

Lab data the maker will actually show you, confirming the CBD content and a low or undetectable THC result, from a business established enough for your vet to be comfortable with.
Full cannabinoid profile, confirming CBD content matches the label and THC sits within legal limits.
Heavy metals screening, since hemp readily absorbs lead, arsenic, and cadmium from soil.
Pesticide and microbial screening, particularly important for products grown outside tightly regulated supply chains.

Knowing exactly what is in the bottle is the practical safeguard that matters most in the UK pet market, where unlabelled or contaminated products still circulate.

Treat the following as immediate red flags: no COA available on request, vague or missing lab accreditation details, “THC-free” claims made without a certificate to back them, prices that seem implausibly low for a lab-tested product, or any marketing language suggesting CBD can cure epilepsy. Genuine, transparent suppliers publish this information without you having to chase it, and resources like Elevated Remedies’ guide to CBD safety and sourcing or a COA reference page give a useful sense of what proper lab documentation should actually look like.

Pro Tip: Before buying anything, ask the seller what lab data they can show you and exactly what is in the product. A good maker answers plainly, and your vet can read whatever they send you.

Dosing ranges from trials and a safe titration approach

Trial doses vary more than owners expect, which is exactly why “start low and go slow” under veterinary guidance beats copying a number from the internet. The Frontiers 2022 trial used around 2 mg/kg every 12 hours and still found a statistically significant reduction in mean seizures and seizure days. The Rozental et al. crossover trial, by contrast, pushed adjunctive dosing up toward 9 mg/kg per day, with liver enzymes monitored throughout. Neither dose is automatically “correct” for your dog; body weight, concurrent medication, and individual metabolism all shift where a vet might start you.

A pragmatic, vet-supervised titration plan generally looks like this:

Baseline bloodwork first, including liver enzymes and, where relevant, serum levels of any AED your dog already takes.
Start at the lower end of trial-reported ranges, giving the dose with food to improve absorption and reduce GI upset.
Increase gradually, only after your vet reviews how your dog has responded and tolerated the current dose, not on a fixed weekly schedule you set yourself.
Repeat bloodwork at your vet’s recommended interval, typically within the first four to six weeks of any dose change.
Judge effect over weeks, not days. Seizure frequency naturally fluctuates, so most vets recommend tracking outcomes for at least six to eight weeks before deciding whether CBD is genuinely helping.

Statistic: Correlation between blood CBD concentration and seizure response has been observed in trial data, which is part of why dose titration under monitoring, rather than a single fixed dose for every dog, tends to produce more reliable outcomes.

Our practical UK dosing guide covers how strength and format affect this titration process in more detail, though it should sit alongside veterinary guidance for a dog with an active seizure disorder rather than replace it.

Talking to your vet: what to bring and what to ask

Walking into an appointment prepared makes a genuine difference to how useful the conversation is. Bring three things: a seizure diary logging date, duration, and severity of each episode; a full list of current medications and doses; and, if your dog is already on a CBD product, its certificate of analysis.

Once you’re there, a few questions tend to move the conversation forward productively:

Is the prescribing cascade a realistic option for my dog’s specific epilepsy diagnosis, and would that involve a human-licensed product like Epidyolex?
What monitoring would you recommend if we did start CBD, and how often would you want bloodwork repeated?
What signs would tell us to stop immediately, versus what’s a normal early adjustment period?
At what point would you refer us to a veterinary neurologist if seizures remain poorly controlled?

Keep tracking outcomes the same way after the appointment as before it: frequency, severity, and any side effects, logged consistently. If seizures worsen, side effects escalate, or control simply isn’t improving after a reasonable trial period, that’s the point to raise referral again rather than persist alone.

Honest CBD Co’s testing standards and where this article’s limits sit

This article draws on peer-reviewed veterinary trials and UK regulatory guidance, but it isn’t a substitute for a vet who’s examined your dog. Honest CBD Co is a UK, family-run producer, and our approach to transparency shapes how we talk about this topic:

Everything is handcrafted in small runs, the CBD is lab-tested at source, and certificates of analysis are gladly shared, with your vet included.
Our range is made and labelled for people; plenty of customers use it with their dogs, and what is right for a dog with epilepsy is a decision for the vet treating it.
We are rated Excellent on Trustpilot across more than 700 reviews, built on consistent quality and straightforward answers.
We don’t market any product as a treatment or cure for epilepsy, in line with the VMD’s current position on unauthorised veterinary CBD products.
We’d always encourage a conversation with your vet before introducing CBD to a dog with a seizure disorder, whatever product you’re considering.

A balanced closing view on CBD for canine epilepsy

The honest position is this: CBD looks like a real, if modest, adjunct for some dogs with drug-resistant epilepsy, not a breakthrough cure and not snake oil either. The dogs who benefit most seem to be those already on conventional AEDs whose seizures aren’t fully controlled. Where this goes wrong is when owners treat CBD as a standalone substitute or skip the bloodwork that catches liver strain early. Speak to your vet, start a seizure diary today, and let the evidence, not the marketing, set your expectations.

Richard

Where to start if your vet approves a CBD trial

If your vet agrees that CBD is worth trying alongside your dog’s existing treatment, sourcing matters as much as the decision itself. Honest CBD Co produces UK-made, small-batch full-spectrum CBD oil with the exact strength in milligrams on every label, the CBD lab-tested at source, and certificates of analysis your vet can see on request.

For dogs on a strict veterinary titration plan, a dropper oil is the right tool because doses move in small steps: our Full Spectrum CBD Oil (10ml, 10% at £25.99 or 20% at £37.99) gives roughly 5mg or 10mg per drop, which makes gradual, vet-directed increases straightforward to manage at home. The recommended flow stays the same: vet consultation first, a monitored trial second, and a clearly labelled product once your vet has confirmed it is appropriate for your dog. Our dog dosage guide covers the weight-band arithmetic to take into that conversation.

Sources

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.